Elevai Labs, Inc. (ELAB) Balance Sheet

NASDAQ: ELABAssets, liabilities, debt and equity over 6 years.

ELAB balance sheet, 2025

December 31, 2025 · U.S. dollars

$12.9M assets = $5.0M liabilities + $7.8M equity

What it owns$12.9MCash & ST investments: $5.4M (42.0%)Cash & ST investments$5.4M · 42%Receivables: $340,531 (2.6%)Inventory: $95,098 (0.7%)Other current: $1.0M (8.0%)Other current $1.0MPP&E: $2.1M (16.5%)PP&E$2.1M · 17%Goodwill & intangibles: $3.9M (30.1%)Goodwill & intangibles$3.9M · 30%=How it is financed$12.9MCurrent liabilities: $3.9M (30.6%)Current liabilities$3.9M · 31%Long-term debt: $85,000 (0.7%)Other LT liabilities: $1.0M (7.8%)Other LT liabilities $1.0MShareholders’ equity: $7.8M (60.9%)Shareholders’ equity$7.8M · 61%

Both columns are drawn to the same scale: what ELAB owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ELAB financial health

Current ratio1.74
Comfortable · current assets cover current liabilities 1.74×
Debt / equity0.34
Low leverage · $0.34 of debt for each $1 of equity
Equity / assets60.9%
Equity-funded · of assets funded by shareholders
Cash / debt204.3%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles30.1%
Acquisition-heavy · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ELAB balance sheet trends, 2020–2025

Elevai Labs, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$17,0222020$12.9M2025+276.4%/yr
Total liabilities$40,6112020$5.0M2025+162.2%/yr
Shareholders’ equity−$23,5892020$7.8M2025—
Cash & short-term investments$13,3512020$5.4M2025+232.2%/yr
Total debt$24,0002020$2.6M2025+156.1%/yr
Net cash (debt)−$10,6492020$2.8M2025+$2.8M
Working capital−$23,5892020$2.9M2025+$3.0M
Current ratio0.4220201.742025+1.32
Debt / equity0.2520220.342025+0.09

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ELAB assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ELAB liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ELAB debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ELAB balance sheet

Elevai Labs, Inc. annual balance sheet
202520242023202220212020
Assets
Cash & short-term investments$5.4M$4.0M$3.3M$1.2M$411,858$13,351
Cash & equivalents$5.4M$4.0M$3.3M$1.2M$411,858$13,351
Short-term investments$572,054$0————
Receivables$340,531$5,276$36,161$12,854$1,710$371
Inventory$95,098$1,044$495,667$230,145$160,817$0
Other current assets$1.0M$2.1M$1.1M$153,422$62,140$3,300
Total current assets$6.9M$6.1M$4.9M$1.6M$636,525$17,022
Property, plant & equipment (net)$2.1M$1,087$1,741$330,088$29,725$0
Goodwill & intangible assets$3.9M$2.8M$0$0$0$0
Long-term investments$0$139,084$0$0$0$0
Other non-current assets$0$1$268,733$10,773$0$0
Total assets$12.9M$9.0M$5.2M$1.9M$666,250$17,022
Liabilities
Accounts payable$697,633$481,000$596,147$210,840$98,175$154
Short-term debt$1.6M—$145,000$110,616—$24,000
Deferred revenue——$36,693$10,172——
Total current liabilities$3.9M$1.8M$1.3M$588,272$215,622$40,611
Long-term debt$85,000$0$0$0$0$0
Lease obligations$1.2M$0$210,489$283,217$0—
Other long-term liabilities$1.0M$534,467$65,489$172,601$0$0
Total liabilities$5.0M$2.3M$1.4M$760,873$215,622$40,611
Shareholders' equity
Common stock & paid-in capital$8$44$1,733$957$952$848
Retained earnings (deficit)−$21.0M−$13.3M−$7.0M−$2.7M−$922,105−$137,366
Accumulated other comprehensive income−$2,339−$337$202$111$202−$1,222
Total shareholders' equity$7.8M$6.7M$3.8M$1.1M$450,628−$23,589
Key figures
Total debt$2.6M—$210,489$283,217—$24,000
Net cash (debt)$2.8M—$3.1M$871,684—−$10,649
Working capital$2.9M$4.3M$3.6M$963,050$420,903−$23,589
Tangible book value$4.0M$3.9M$3.8M$1.1M$450,628−$23,589
Current ratio1.743.363.792.642.950.42
Quick ratio1.462.222.591.991.920.34
Debt / equity0.34—0.050.25——
Equity / assets60.9%74.1%73.7%59.8%67.6%−138.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.

ELAB financial position

At the end of fiscal 2025 (December 31, 2025), Elevai Labs had total assets of $12.9 million (up 43.1% from a year earlier), total liabilities of $5.0 million and shareholders' equity of $7.8 million. It held $5.4 million in cash and short-term investments against $2.6 million of debt, a net cash position of $2.8 million. Its current ratio was 1.74. In the latest quarter (ended June 30, 2026) total assets were $36.6 million and equity $16.7 million.

Related: ELAB income statement, ELAB cash flow statement, ELAB key metrics. See the ELAB stock overview for the latest quote and news.

ELAB balance sheet FAQ

What are Elevai Labs's total assets?

Elevai Labs reported total assets of $12.9 million at the end of fiscal 2025 (December 31, 2025), compared with $9.0 million a year earlier.

How much debt does Elevai Labs have?

Elevai Labs had $2.6 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.34.

How much cash does Elevai Labs have?

Elevai Labs held $5.4 million in cash and short-term investments at the end of fiscal 2025; with $2.6 million of debt that is net cash of $2.8 million.

What is Elevai Labs's book value?

Elevai Labs's shareholders' equity (book value) was $7.8 million at the end of fiscal 2025.

What is Elevai Labs's current ratio?

Elevai Labs had current assets of $6.9 million and current liabilities of $3.9 million, a current ratio of 1.74 (it can cover its short-term obligations).

How much goodwill does Elevai Labs have?

Elevai Labs carried $3.9 million of goodwill and intangible assets, 30.1% of total assets, at the end of fiscal 2025.

Biotechnology: balance sheet